BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Trevena Reports Third Quarter 2024 Results and Provides Business Update

  November 8, 2024

   · 

  19 min read
• Press Releases

  Harvard Bioscience Announces Third Quarter 2024 Financial Results

  November 8, 2024

   · 

  13 min read
• Press Releases

  Altimmune Announces Successful Completion of End-of-Phase 2 Meeting with FDA for Pemvidutide in the Treatment of Obesity

  November 8, 2024

   · 

  6 min read
• Press Releases

  Quotient Therapeutics Appoints Sir Mene Pangalos, Ph.D. to Board of Directors

  November 8, 2024

   · 

  3 min read
• Press Releases

  23andMe to Report Q2 FY2025 Financial Results

  November 8, 2024

   · 

  3 min read
• Press Releases

  Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market

  November 8, 2024

   · 

  7 min read
• Press Releases

  Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

  November 8, 2024

   · 

  8 min read
• Press Releases

  Late-Breaking Clinical Data and Real-World Evidence Presented at HIV Glasgow as Gilead Extends Leadership Efforts Toward Ending the Epidemic

  November 8, 2024

   · 

  19 min read
• Press Releases

  Werewolf Therapeutics Presents Preclinical and Clinical Data at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

  November 8, 2024

   · 

  7 min read
• Press Releases

  Harbinger Health Announces New Partnership with Leading Cancer Center to Accelerate Clinical Evidence Generation

  November 8, 2024

   · 

  3 min read